Gayatri Saberwal

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Trials

PLOS global public health

PloS one

Orphanet journal of rare diseases

Institute of Bioinformatics and Applied Biotechnology

Centre for Cellular and Molecular Biology CSIR (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Bioinformatics and Applied Biotechnology

India

Faculty Scientist and Dean (Academic Affairs)

Education History

Centre for Cellular and Molecular Biology CSIR

India

PHD

Publications

Gayatri Saberwal
The need for a new keyword - "Trial registry-metaresearch" - to track certain uses of clinical trial registry records. Trials 24 (1) (2023)
Gayatri Saberwal
The need for a new keyword - "Trial registry-metaresearch" - to track certain uses of clinical trial registry records. Trials 24 (1) (2023)
Jaishree Mendiratta, Ravi N Vaswani, Gayatri Saberwal
Representation from India in multinational, interventional, phase 2 or 3 trials registered in Clinical Trials Registry-India: A cross-sectional study. PloS one 18 (9) (2023)
Gayatri Saberwal
The need for a new keyword - "Trial registry-metaresearch" - to track certain uses of clinical trial registry records. Trials 24 (1) (2023)
Mohua Chakraborty Choudhury, Indraneel Chakraborty, Gayatri Saberwal
Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data. PLOS global public health 2 (4) (2022)
Indraneel Chakraborty, Adya Shreya, Jaishree Mendiratta, Anant Bhan, Gayatri Saberwal
An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry-India. PLOS global public health 2 (10) (2022)
Monoswi Chakraborty, Mohua Chakraborty Choudhury, Indraneel Chakraborty, Gayatri Saberwal
Rare disease patients in India are rarely involved in international orphan drug trials. PLOS global public health 2 (8) (2022)
Kishan Kalia, Gayatri Saberwal, Gaurav Sharma
The lag in SARS-CoV-2 genome submissions to GISAID. Nature biotechnology 39 (9) (2021)
Nisha Venugopal, Gayatri Saberwal
A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one. PloS one 16 (5) (2021)
Sangeeta Kumari, Abhilash Mohan, Gayatri Saberwal
Hidden duplicates: 10s or 100s of Indian trials, registered with ClinicalTrials.gov, have not been registered in India, as required by law. PloS one 15 (6) (2020)
Mounika Pillamarapu, Abhilash Mohan, Gayatri Saberwal
Response to the Letter on: "An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India". Trials 21 (1) (2020)
Neha Chaturvedi, Bagish Mehrotra, Sangeeta Kumari, Saurabh Gupta, H S Subramanya, Gayatri Saberwal
Some data quality issues at ClinicalTrials.gov. Trials 20 (1) (2019)
Mohua Chakraborty Choudhury, Gayatri Saberwal
The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study. Orphanet journal of rare diseases 14 (1) (2019)
Mounika Pillamarapu, Abhilash Mohan, Gayatri Saberwal
An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India. Trials 20 (1) (2019)
Mohua Chakraborty Choudhury, Gayatri Saberwal
The role of patient organizations in the rare disease ecosystem in India: an interview based study. Orphanet journal of rare diseases 14 (1) (2019)

Gayatri Saberwal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gayatri Saberwal